DICLOXACILLIN AND FLUCLOXACILLIN INDUCE CYP3A4 AND CYP2C9 IN HUMAN HEPATOCYTES.

被引：0
|
作者：
Stage, T. B. [1 ]
Wong, S. [2 ]
Kroetz, D. L. [1 ]
Khojasteh, C. [2 ]
机构：
[1] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA
[2] Genentech Inc, DMPK, San Francisco, CA 94080 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2017年 / 101卷 / S1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-107
引用
收藏
页码：S47 / S48
页数：2
相关论文
共 50 条
  • [21] CONTRIBUTION OF UGT1A1, CYP2A6, CYP2C9, AND CYP3A4 IN METABOLISM OF BELINOSTAT
    Luo, Gang
    Schicker, Michael
    Lee, Deborah
    Leitz, Sara
    McKenzie, Donald
    Albaugh, Daniel
    Reddy, Guru
    DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (01) : S59 - S59
  • [22] Role of CYP2C9 and its variants (CYP2C9*3 and CYP2C9*13) in the metabolism of lornoxicam in humans
    Guo, YJ
    Zhang, YF
    Wang, Y
    Chen, XY
    Si, DY
    Zhong, DF
    Fawcett, JP
    Zhou, H
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (06) : 749 - 753
  • [23] Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes
    Hijazi, Y
    Boulieu, R
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (07) : 853 - 858
  • [24] Inhibition of CYP3A4 and CYP2C9 by podophyllotoxin: Implication for clinical drug-drug interactions
    Song, Jin-Hui
    Sun, Dong-Xue
    Chen, Bin
    Ji, Dai-Hong
    Pu, Jie
    Xu, Jie
    Tian, Feng-De
    Guo, Lin
    JOURNAL OF BIOSCIENCES, 2011, 36 (05) : 879 - 885
  • [25] The inhibition of noscapine to CYP3A4 and CYP2C9: explanation for clinical DDI between noscapine and warfarin
    Fang, Zhong-Ze
    Yang, Ling
    DRUG METABOLISM REVIEWS, 2009, 41 : 74 - 74
  • [26] Effects of polymorphic variation on the thermostability of heterogenous populations of CYP3A4 and CYP2C9 enzymes in solution
    Lauren B. Arendse
    Jonathan M. Blackburn
    Scientific Reports, 8
  • [27] Effects of polymorphic variation on the thermostability of heterogenous populations of CYP3A4 and CYP2C9 enzymes in solution
    Arendse, Lauren B.
    Blackburn, Jonathan M.
    SCIENTIFIC REPORTS, 2018, 8
  • [28] Kinetic analysis of fluvastatin metabolism by CYP2C9 and its allelic variants, CYP2C9*2 and CYP2C9*3
    Einolf, HJ
    Fischer, V
    DRUG METABOLISM REVIEWS, 2003, 35 : 191 - 191
  • [29] Catalytic roles of CYP2C9 and its variants (CYP2C9*2 and CYP2C9*3) in lornoxicam 5′-hydroxylation
    Iida, I
    Miyata, A
    Arai, M
    Hirota, M
    Akimoto, M
    Higuchi, S
    Kobayashi, K
    Chiba, K
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (01) : 7 - 9
  • [30] CYP3A4, CYP3A5 and CYP2C9 are responsible for the N-demethylation of meperidtne to normeperidine in vitro.
    Santucci, R
    Innocenti, F
    Ramirez, J
    House, L
    Ratain, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P79 - P79
12345